{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:54:05Z","timestamp":1791024845622,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1053\/j.gastro.2004.08.002","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T18:31:14Z","timestamp":1122661874000},"page":"1347-1355","source":"Crossref","is-referenced-by-count":274,"title":["Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients"],"prefix":"10.1053","volume":"127","author":[{"given":"Holger","family":"Hinrichsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel E.","family":"Sentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Cr\u00f6nlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo L.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Loi","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Nehmiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard G.","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1053\/j.gastro.2004.08.002_bib1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2004.08.002_bib2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/hep.1840360705","article-title":"The burden of hepatitis C in the United States","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2004.08.002_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1053\/j.gastro.2004.08.002_bib4","first-page":"S35","article-title":"Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the viral hepatitis prevention board","volume":"6","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2004.08.002_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(00)02603-9","article-title":"Normalised intrinsic mortality risk in liver transplantation","volume":"356","author":"Adam","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2004.08.002_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-2893.2001.00291.x","article-title":"Hepatitis C virus genotypes","volume":"8","author":"Fattovich","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2004.08.002_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.51.3.429","article-title":"Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients","volume":"51","author":"Hinrichsen","year":"2002","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2004.08.002_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1440-1746.2002.02777.x","article-title":"Hepatitis C advances in antiviral therapy","volume":"17","author":"McHutchison","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2004.08.002_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1198-743x.2001.00389.x","article-title":"Present treatment expectations and risks of chronic hepatitis C","volume":"8","author":"Carreno","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2004.08.002_bib10","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1002\/hep.1840360718","article-title":"Treatment of chronic hepatitis C","volume":"36","author":"Chander","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2004.08.002_bib11","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.1840360716","article-title":"Optimal therapy of hepatitis C","volume":"36","author":"Di Bisceglie","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2004.08.002_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/gast.1999.0029900408","article-title":"Interferon-ribavirin for chronic hepatitis C with and without cirrhosis","volume":"117","author":"Schalm","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2004.08.002_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2004.08.002_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2004.08.002_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.285.2.193","article-title":"Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon","volume":"285","author":"Cummings","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2004.08.002_bib16","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/hep.1840360707","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Marcellin","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2004.08.002_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2004.08.002_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(02)00413-0","article-title":"A comparison of fibrosis progression in chronic liver diseases","volume":"38","author":"Poynard","year":"2003","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2004.08.002_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.gastro.2004.08.002_bib20","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/JVI.67.7.3835-3844.1993","article-title":"Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3\/4 and NS4\/5 junctions","volume":"67","author":"Bartenschlager","year":"1993","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2004.08.002_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/JVI.67.3.1385-1395.1993","article-title":"Expression and identification of hepatitis C virus polyprotein cleavage products","volume":"67","author":"Grakoui","year":"1993","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2004.08.002_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0092-8674(00)81351-3","article-title":"Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide","volume":"87","author":"Kim","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2004.08.002_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81350-1","article-title":"The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site","volume":"87","author":"Love","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2004.08.002_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2004.08.002_bib25","first-page":"363A","article-title":"Tolerability and pharmacokinetics of BILN 2061, a novel oral HCV serine protease inhibitor, after oral single doses of 5 to 2400 mg in healthy male subjects","volume":"36","author":"Narjes","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2004.08.002_bib26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/jhep.2000.17709","article-title":"Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays","volume":"32","author":"Sarrazin","year":"2000","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2004.08.002_bib27","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/hep.1840360709","article-title":"Use and interpretation of virological tests for hepatitis C","volume":"36","author":"Pawlotsky","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2004.08.002_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.2517-6161.1948.tb00014.x","article-title":"A probability distribution derived from the binomial distribution by regarding the probability of success as variable between the sets of trials","volume":"10","author":"Skellam","year":"1948","journal-title":"J R Stat Soc B"},{"key":"10.1053\/j.gastro.2004.08.002_bib29","first-page":"136","article-title":"Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1","volume":"37","author":"Reiser","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2004.08.002_bib30","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1128\/JVI.78.14.7352-7359.2004","article-title":"Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor 2061","volume":"78","author":"Thibeault","year":"2004","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2004.08.002_bib31","doi-asserted-by":"crossref","first-page":"17508","DOI":"10.1074\/jbc.M313020200","article-title":"In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061","volume":"279","author":"Lin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2004.08.002_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"10.1053\/j.gastro.2004.08.002_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep.510280132","article-title":"Hepatitis C virus dynamics in vivo","volume":"28","author":"Zeuzem","year":"1998","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508504013915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508504013915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:00:51Z","timestamp":1735848051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508504013915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0016508504013915"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2004.08.002","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}